LINDSAY ADAMS: Open Payments
NPI 1235852757 · CRESTVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 43 payments from 17 companies in 2025. Trend: 2023 $854 · 2024 $739 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $185 |
| Novo Nordisk Inc | 10 | $151 |
| Dexcom, Inc. | 3 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $87 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Exact Sciences Corporation | 3 | $44 |
| Novartis Pharmaceuticals Corporation | 3 | $44 |
| Corium, LLC | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
Products named: Dexcom G6 Transmitter, XIFAXAN, Ozempic, Rybelsus, Auvelity, The Cologuard Plus Collection Kit, LEQVIO, Azstarys.
Industry payments across FL — which companies pay providers there.
